CD8A and influenza: Compared to the moderate enhancement of CD8+ T cell activation in influenza infection, IL-2 treatment in acute LCMV infection caused a stronger activation of CD8+ T cells (Fig 3E–3H), which might break down the immune tolerance and result in CD8+ T cell-mediated tissue immunopathology.